Pharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver function. [electronic resource]
Producer: 20111212Description: 1205-12 p. digitalISSN:- 1552-4604
- Aged
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Ascites -- physiopathology
- Female
- Half-Life
- Hepatic Insufficiency -- etiology
- Humans
- Liposomes
- Liver Neoplasms -- drug therapy
- Male
- Melanoma -- blood
- Metabolic Clearance Rate
- Middle Aged
- Neoplasm Staging
- Pharmaceutical Vehicles -- therapeutic use
- Skin Neoplasms -- blood
- Survival Analysis
- Tubulin Modulators -- administration & dosage
- Uveal Neoplasms -- blood
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.